Women's Phase 1
Natural health product licensed in Canada
- Other names
- Women's Phase-1, Women's Premenstrual
- Licence holder
- Vitanica
- NPN or DIN-HM
- 80070387
- Status
- Active licence
- Licence date
- 16 June 2016
- Revision date
- 13 June 2024
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 25 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Vitamine B6: up to 25 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (12 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
- Conditions légales
Vitex agnus-castus L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Dioscorea villosa L.: Les matières premières végétales doivent avoir subi les étapes traditionnelles d'épluchage, de lavage et de traitement thermique. L'absence d'alcaloïdes et de composés cyanogènes doit être démontrée par des bulletins d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Borago officinalis L.: Les préparations de cette plante sont autorisées s'il peut être démontré qu'elles ne dépassent pas 1 ppb d'alcaloïdes pyrrolizidiniques.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitex agnus-castus Source : Fruit | 25 milligramme | Not calculated |
| Vitamine B6 Source : 5-phosphate de pyridoxal | 12.5 milligramme | 25,000 µg |
| Taraxacum officinale Source : Feuille | 50 milligramme | Not calculated |
| Magnésium Source : Citrate malate de magnésium | 50 milligramme | 100,000 µg |
| Vitex agnus-castus Source : Fruit Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 125 milligramme | 12.5 milligramme | Not calculated |
| Ginkgo biloba Source : Feuille Extract : Matériel brut sec Extraction ratio : 40:1 Dry plant equivalent : 300 milligramme | 7.5 milligramme | Not calculated |
| Hypericum perforatum Source : Sommité | 50 milligramme | Not calculated |
| Passiflora incarnata Source : Plante entière Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 250 milligramme | 50 milligramme | Not calculated |
| Dioscorea villosa Source : Racine et rhizome | 50 milligramme | Not calculated |
| Angelica sinensis Source : Racine | 50 milligramme | Not calculated |
| Borago officinalis Source : Plante entière | 75 milligramme | Not calculated |
| Vitamine E Source : D-alpha-tocophéryl succinate | 100 UI | Not calculated |
| Calcium Source : Citrate malate de calcium | 25 milligramme | 50,000 µg |
| Iode Source : Iode | 37.5 microgrammes | Not calculated |
| Chrome Source : Picolinate de chrome (III) | 50 microgrammes | Not calculated |
Non-medicinal ingredients
Cellulose, Eau
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 1 day |
Uses authorised in Canada
Used in Herbal Medicine to help relieve premenstrual symptoms. Used in Herbal Medicine as a hormone normaliser to help stabilise menstrual cycle irregularities. A factor in the maintenance of good health. Used to help relieve premenstrual symptoms.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
If you experience breast pain, discomfort and/or tenderness, discontinue use and consult a health care practitioner. Hypersensitivity (e.g. allergy) has been known to occur; in which case, discontinue use. Some people may experience drowsiness. Exercise caution if operating heavy machinery, driving a motor vehicle or involved in activities requiring mental alertness. Some people may experience mild gastrointestinal disturbances, nausea, restlessness and/or headaches.
- Contre-indications
Do not use if you are pregnant, breastfeeding, or attempting to conceive unless you have consulted with a healthcare practitioner.
- Précautions et mises en garde
Consult a health care practitioner if symptoms persist. Consult a health care practitioner if symptoms worsen. Consult a health care practitioner prior to use if you are taking hormone-containing medications such as progesterone preparations, oral contraceptives or hormone replacement therapy. Consult a health care practitioner prior to use if you have a kidney disorder and/or diabetes. If you have liver or gall bladder diseases, and/or intestinal obstruction, consult a health care practitioner prior to use. If menstruation is delayed or absent, or if you experience increased menstrual bleeding time, discontinue use and consult a health care practitioner. If you are taking blood thinners/ anticoagulants, consult a health care practitioner prior to use. If you are taking hormone replacement therapy (HRT), consult a health care practitioner prior to use. If you have family history of cancer, consult a healthcare practitioner prior to use. Some people may experience drowsiness. Exercise caution if operating heavy machinery, driving a motor vehicle or involved in activities requiring mental alertness. Hypersensitivity (e.g. allergy) has been known to occur; in which case, discontinue use. If you have allergy/hypersensitivity to members of the Apiaceae/Umbelliferae family (anise, caraway, carrot, celery, dill, parsley), do not use this product. If you have diarrhoea or haemorrhagic diseases, do not use this product. If you have hypermenorrhoea/ profuse menstrual flow/ heavy periods, do not use this product. Consult a health care practitioner prior to use if you are taking anti-anxiety medications, seizure medications, antihistamines, bronchodilators, muscle relaxants and/or opiates. Avoid prolonged exposure to sunlight, ultraviolet light (UV) or UV therapy. Do not use if you are taking anti-cancer medications, blood thinners, antidepressant medications (e.g. selective serotonin reuptake inhibitors (SSRI)), anti-HIV agents, cardiovascular medications, and/or immunosuppressants. Consult a health care practitioner prior to use if you are taking hormone-containing medications such as progesterone preparations, oral contraceptives or hormone replacement therapy. If you have low blood pressure, edema (swelling of hands, face and feet) or are taking other diuretic products, do not use. stop use and seek medical attention immediately if you experinece dizziness, confusion, muscle weakness or pain, abnormal heartbeat and/or difficulty breathing.
Source
Official Health Canada record, licence 80070387
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging